Consolidated Balance Sheets (USD $) In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2013: $147; 2012: $146)	$ 5,940	$ 4,318
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2013: $148; 2012: $121)	4,935	5,074
Other	4,712	4,605
Inventories	8,303	8,476
Deferred income tax assets - current	743	877
Other current assets	344	334
Total current assets	24,977	23,684
Investments
Investment in nonconsolidated affiliates	4,501	4,121
Other investments (investments carried at fair value - 2013: $2,056; 2012: $2,061)	2,541	2,565
Noncurrent receivables	365	313
Total investments	7,407	6,999
Property
Property	55,114	54,366
Less accumulated depreciation	37,660	36,846
Net property (variable interest entities restricted - 2013: $2,646; 2012: $2,554)	17,454	17,520
Other Assets
Goodwill	12,798	12,739
Other intangible assets (net of accumulated amortization - 2013: $3,270; 2012: $2,785)	4,314	4,711
Deferred income tax assets - noncurrent	1,964	3,333
Asbestos-related insurance receivables - noncurrent	86	155
Deferred charges and other assets	501	464
Total other assets	19,663	21,402
Total Assets	69,501	69,605
Current Liabilities
Notes payable	443	396
Long-term debt due within one year	697	672
Accounts payable:
Trade	4,590	5,010
Other	2,290	2,327
Income taxes payable	435	251
Deferred income tax liabilities - current	133	95
Dividends payable	467	86
Accrued and other current liabilities	2,916	2,656
Total current liabilities	11,971	11,493
Long-Term Debt (variable interest entities nonrecourse - 2013: $1,360; 2012: $1,406)	16,820	19,919
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	718	837
Pension and other postretirement benefits - noncurrent	8,176	11,459
Asbestos-related liabilities - noncurrent	434	530
Other noncurrent obligations	3,302	3,353
Total other noncurrent liabilities	12,630	16,179
Redeemable Noncontrolling Interest	156	147
Stockholders' Equity
Preferred stock, series A ($1.00 par, $1,000 liquidation preference, 4,000,000 shares)	4,000	4,000
Common stock (authorized 1,500,000,000 shares of $2.50 par value each;issued 2013: 1,213,405,223 shares; 2012: 1,203,292,822 shares)	3,054	3,008
Additional paid-in capital	3,928	3,281
Retained earnings	21,407	18,495
Accumulated other comprehensive loss	(4,827)	(7,516)
Unearned ESOP shares	(357)	(391)
Treasury stock at cost (2013: 8,152,030 shares; 2012: zero shares)	(307)	0
The Dow Chemical Company's stockholders' equity	26,898	20,877
Noncontrolling interests	1,026	990
Total equity	27,924	21,867
Total Liabilities and Equity	$ 69,501	$ 69,605